Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients

Conditions: Pulmonary Arterial Hypertension Interventions: Drug: Generic treprostinil sodium + Standard of Care (Double Oral); Drug: Standard of Care - Double Oral Sponsors: AOP Orphan Pharmaceuticals AG; ANOVA CRO s.r.o.; PharmaLex Belgium; Aixial s.r.o.; GCP-Service International Ltd.& Co. KG Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials